Ropivacaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Ropivacaine Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 03/23/2018. Reported reason: Demand increase for the drug
Shortage Details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-287-20
- Dosage Form
- Injection
- Presentation
- Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20)
- Initial Posting
- 03/23/2018
- Revised Date
Reason
Demand increase for the drug